Current Opinion in Neurology

Article	Citations
The role of innate immune genes in Alzheimer's disease	110
Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management	98
Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease	63
MRI findings as markers of idiopathic intracranial hypertension	56
Motion sickness: current concepts and management	49
What is ‘Alzheimer's disease’? The neuropathological heterogeneity of clinically defined Alzheimer's dementia	48
The state of telemedicine for persons with Parkinson's disease	48
Acute bacterial meningitis	45
Update on neuroimaging in disorders of consciousness	42
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration	42
Update on genetics of amyotrophic lateral sclerosis	37
Advances in the treatment of neuropathic pain	36
Neuralgic amyotrophy	32
Dravet syndrome	32
Fragile X-associated tremor/ataxia syndrome: pathophysiology and management	31
Lesion network mapping for symptom localization: recent developments and future directions	31
MRI in disorders of consciousness	29
Overview of tau PET molecular imaging	26
Vaccinations in multiple sclerosis patients receiving disease-modifying drugs	26
Functional MRI in migraine	25
Vestibular and auditory manifestations of migraine	25
Neuromuscular complications of coronavirus disease-19	22
Autoimmune nodopathies, an emerging diagnostic category	22
Deep brain stimulation in dystonia: factors contributing to variability in outcome in short and long term follow-up	22
Central nervous system tuberculosis	21

Stroke epidemiology and COVID-19 pandemic	21
Interictal autonomic dysfunction	21
New drugs for multiple sclerosis: new treatment algorithms	21
Microglia in multiple sclerosis – pathogenesis and imaging	20
Rehabilitation of cortically induced visual field loss	20
Intravenous thrombolysis for acute ischemic stroke: why not?	19
Use of disease-modifying drugs during pregnancy and breastfeeding	19
Learning from the comorbidities of epilepsy	19
Reproducibility and replicability in neuroimaging data analysis	19
Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis	18
Management of autoimmune encephalitis	18
Optic neuropathy and diplopia from thyroid eye disease: update on pathophysiology and treatment	18
Ménière's disease: new guidelines, subtypes, imaging, and more	18
Recent advances in pharmacotherapy for epilepsy	17
Long COVID and especially headache syndromes	17
Advances in the genetic classification of amyotrophic lateral sclerosis	17
What have we learned from cognition in the oldest-old	17
Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis	17
The recent surge of functional movement disorders: social distress or greater awareness?	17
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases	16
Ataxin-2 gene: a powerful modulator of neurological disorders	16
Chemotherapy and targeted therapies for meningiomas: what is the evidence?	16
Central vein sign and iron rim in multiple sclerosis: ready for clinical use?	16
Current concepts in acute vestibular syndrome and video-oculography	16
Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and management	16
Insular seizures and epilepsies: Ictal semiology and minimal invasive surgery	16
Updates on ophthalmic imaging features of optic disc drusen, papilledema, and optic disc edema	15
Neuropathogenesis of acute coronavirus disease 2019	15
Peripheral white blood cell responses as emerging biomarkers for patient stratification and prognosis in acute spinal cord injury	15
Traumatic peripheral nerve injuries: diagnosis and management	15
Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinations	15
Methods of visual assessment in children with cortical visual impairment	15
Immunotherapy in autoimmune encephalitis	14
Unveiling the neuroimaging-genetic intersections in the human brain	14
Update on neuroimaging in brain tumours	14
Parkinson's disease – genetic cause	14
Targets for migraine treatment: beyond calcitonin gene-related peptide	14
The current landscape of epilepsy genetics: where are we, and where are we going?	14
Biomarkers for amyotrophic lateral sclerosis	14
Influence of sex hormones on vestibular disorders	13
Antibody testing in neuropathy associated with anti-Myelin-Associated Glycoprotein antibodies: where we are after 40 years	13
A reappraisal of injuries and accidents in people with epilepsy	13
Attention deficit/hyperactivity disorder and epilepsy	13
Novel pathophysiological insights in autoimmune myasthenia gravis	13
Oculopharyngodistal myopathy	13
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies	13
Therapeutic strategies for C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia	13
Data-driven approaches to neuroimaging biomarkers for neurological and psychiatric disorders: emerging approaches and examples	12
Bilateral vestibulopathy: the causes, diagnosis, and treatments	12
Sudden unexpected death in epilepsy	12

Expanding the clinical spectrum of idiopathic intracranial hypertension	12
Vestibular-autonomic interactions: beyond orthostatic dizziness	12
Equitable partnerships between scientists and persons living with spinal cord injury will strengthen research scope, quality, and outcomes	12
Triggers of migraine: where do we stand?	12
Dysregulation of energy homeostasis in amyotrophic lateral sclerosis	12
Telemedicine for neuro-ophthalmology: challenges and opportunities	12
Update on the management of status epilepticus	12
Neuropathology and neuroanatomy of TDP-43 amyotrophic lateral sclerosis	12
Vestibular function testing in the 21st century: video head impulse test, vestibular evoked myogenic potential, video nystagmography; which tests will provide answers?	12
Brief exposure to systemic hypoxia enhances plasticity of the central nervous system in spinal cord injured animals and man	12
Update on dermatomyositis	11
Advanced neuroimaging techniques in epilepsy	11
The role of telemedicine in acute stroke treatment in times of pandemic	11
Novel approaches to prediction in severe brain injury	11
Fluid phase biomarkers in multiple sclerosis	11
Connecting tremors – a circuits perspective	11
Serotonergic therapy in epilepsy	11
Autoimmune movement disorders with neuronal antibodies – an update	11
The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas	11
Highly effective disease-modifying treatment as initial MS therapy	11
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	10
New insights into the Immune TME of adult-type diffuse gliomas	10
Cancer stem cells in gliomas: evolving concepts and therapeutic implications	10
Predicting disability worsening in relapsing and progressive multiple sclerosis	10
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	10
Deciphering the contributions of neuroinflammation to neurodegeneration: lessons from antibody-mediated encephalitis and coronavirus disease 2019	10
Immunotherapy approaches for adult glioma: knowledge gained from recent clinical trials	10
Visual field defects in temporal lobe epilepsy surgery	10
Assessment and treatment of neurogenic dysphagia in stroke and Parkinson's disease	9
Network dysfunction in pre and postsurgical epilepsy: connectomics as a tool and not a destination	9
Progress in spinal muscular atrophy research	9
Update in the clinical application of focused ultrasound	9
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	9
Update on alpha-synuclein-based biomarker approaches in the skin, submandibular gland, gastrointestinal tract, and biofluids	9
Advances in the management of acute ischemic stroke	9
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	9
Hereditary motor neuropathies	8
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	8
Is chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas?	8
Cerebellar ataxia, neuropathy, vestibular areflexia syndrome: genetic and clinical insights	8
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?	8
Sudden unexpected death in epilepsy	8
Autoimmune neuromyotonia	8
Recent advances in our understanding of genetic rhabdomyolysis	8
Update on neuroimaging for categorization of Parkinson's disease and atypical parkinsonism	8
COVID-19 associated myopathy	8
The FSHD jigsaw: are we placing the tiles in the right position?	8
Facial pain beyond trigeminal neuralgia	8
Contraception, fecundity, and pregnancy in women with epilepsy: an update on recent literature	8
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies	8
Socioeconomic disparities in epilepsy care	8
Small fiber neuropathies: expanding their etiologies	8
Targeting IDH1/IDH2 mutations in gliomas	8
Interrogating large multiple sclerosis registries and databases: what information can be gained?	8
Digital health in stroke medicine: what are the opportunities for stroke patients?	8
Historical development and contemporary use of neuromodulation in human spinal cord injury	8
Optic neuritis: current challenges in diagnosis and management	7
Drug interactions and risks associated with the use of triptans, ditans and monoclonal antibodies in migraine	7
Updates on management of headache in women and transgender women	7
Precision medicine in secondary prevention of ischemic stroke: how may blood-based biomarkers help in clinical routine? An expert opinion	7
Noninvasive neuromodulation and rehabilitation to promote functional restoration in persons with spinal cord injury	7
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis	7
Targeting gene fusions in glioma	7
Neuromuscular hyperexcitability syndromes	7
Neurology education in the era of artificial intelligence	7
Promoting exogenous repair in multiple sclerosis: myelin regeneration	7
Recent advances in establishing a cure for GNE myopathy	7
Current drug treatment of myasthenia gravis	7
Emerging infectious encephalitides	7
New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome	6
Combined neuromodulatory approaches in the central nervous system for treatment of spinal cord injury	6
Stroke in the young	6
Peripheral visual field loss and activities of daily living	6
Emerging approaches in neurostimulation for epilepsy	6
Imaging cortical lesions in multiple sclerosis	6
Traumatic brachial plexus injury: diagnosis and treatment	6
Presymptomatic amyotrophic lateral sclerosis: from characterization to prevention	6
Central nervous system infections and antimicrobial resistance: an evolving challenge	6
Update on neuroimaging in non-Alzheimer's disease dementia: a focus on the Lewy body disease spectrum	6
Therapies targeting CGRP signaling for medication overuse headache	6

Vestibular contribution to spatial orientation and navigation	6
Targeting B cells in multiple sclerosis	6
An update on Becker muscular dystrophy	6
The 2020 breakthroughs in early secondary prevention: dual antiplatelet therapy versus single antiplatelet therapy	6
Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease	6
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients	6
Myogenic tremor – a novel tremor entity	6
Prevention of epileptogenesis – are we there yet?	6
Evaluating thunderclap headache	5
Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond	5
Acute stroke treatment during coronavirus disease 2019 pandemic	5
Web-based cognitive assessment in older adults: Where do we stand?	5
Nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies	5
Update on neuroimaging in Alzheimer's disease	5
Neuromuscular junction disorders beyond myasthenia gravis	5
Diagnosing viral encephalitis and emerging concepts	5
Electrical stimulation of the peripheral and central vestibular system	5
Progression in multiple sclerosis – a long-term problem	5
The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes	5
Vision loss and hallucinations: perspectives from neurology and ophthalmology	5
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications	5
MRI and laboratory monitoring of disease-modifying therapy efficacy and risks	5
Microglia at the scene of the crime: what their transcriptomics reveal about brain health	5
Neural substrates of substance use disorders	5
Inclusion body myositis: evolving concepts	5
Update on myelin imaging in neurological syndromes	5
Atypical chronic inflammatory demyelinating polyradiculoneuropathy: recent advances on classification, diagnosis, and pathogenesis	5
Neuromuscular complications of cancer therapy	5
Genetic therapy for congenital myopathies	5
Rescue therapies in epilepsy	5
Therapeutic developments for valosin-containing protein mediated multisystem proteinopathy	4
Central vestibular networking for sensorimotor control, cognition, and emotion	4
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	4
Imaging of sleep disorders in pre-Parkinsonian syndromes	4
Advanced imaging in acute ischemic stroke: an updated guide to the hub-and-spoke hospitals	4
Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment	4
The role of the locus coeruleus/norepinephrine system in the pathogenesis of neurodegenerative disorders: An update	4
Pharmacotherapy of cerebellar and vestibular disorders	4
Update on modifiable risk factors for Alzheimer's disease and related dementias	4
Management of neuropsychiatric symptoms in dementia	4
Abnormal energy metabolism in ALS: a key player?	4
Understanding multiple sclerosis as a disease spectrum: above and below the clinical threshold	4
Shifting acute stroke management to the prehospital setting	4
Diet and migraine: what is proven?	4
Objective and graded calibration of recovery of consciousness in experimental models	4
Medication overuse headache	4
Cycling multisensory changes in migraine: more than a headache	4
Neurological adverse events of immune checkpoint blockade: from pathophysiology to treatment	4
Guillain-Barré syndrome in an era of global infections and 21st century vaccination	4
Hypoventilation syndrome in neuromuscular disorders	4
Cerebrovascular disease in pregnancy and postpartum	4
Glymphatic system dysfunction in neurodegenerative diseases	4
Spinal cord pathology revealed by MRI in traumatic spinal cord injury	4
Current advances in giant cell arteritis	4
Prehospital stroke management and mobile stroke units	4
Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke	4
Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies	3
Novel approaches to measuring neurocognitive functions in Alzheimer's disease clinical trials	3
From basic mechanisms to therapeutic perspectives in cluster headache	3
The role of caffeine in headache disorders	3
Endogenous clues promoting remyelination in multiple sclerosis	3
Recent advances in Alzheimer disease genetics	3
The current clinical perception of myotonic dystrophy type 2	3
Sensory neuronopathies, diagnostic criteria and causes	3
Ambulatory seizure detection	3
New developments in myotonic dystrophies from a multisystemic perspective	3
What visuospatial perception has taught us about the pathophysiology of vestibular migraine	3
Toxin-associated infectious diseases: tetanus, botulism and diphtheria	3
Parkinson's disease – current treatment	3
Promises and pitfalls of imaging-based biomarkers in motor neuron diseases	3
Aging of the vestibular system and its relationship to dementia	3
Neurosyphilis and Lyme neuroborreliosis	3
Exploring the vagus nerve and the inflammatory reflex for therapeutic benefit in chronic spinal cord injury	3
Current avenues of gene therapy in Pompe disease	3
Pure autonomic failure and the differential diagnosis of autonomic peripheral neuropathies	3
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients	3
Central nervous system adverse events of immune checkpoint inhibitors	3
Noninvasive methods to monitor intracranial pressure	3
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	3
New developments in diagnostics and treatment of adult-onset focal dystonia	3
A practical approach to peripheral autonomic neuropathies	3
Can you have a migraine aura without knowing it?	3
Spasticity following brain and spinal cord injury: assessment and treatment	3